Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 209

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I

Open access
Meloni, Antonella, Furcas, Maria, Cetani, Filomena, Marcocci, Claudio, Falorni, Alberto, Perniola, Roberto, Pura, Mikuláš, Bøe Wolff, Anette S., Husebye, Eystein S., Lilic, Desa, Ryan, Kelli R., Gennery, Andrew R., Cant, Andrew J., Abinun, Mario, Spickett, Gavin P., Arkwright, Peter D., Denning, David, Costigan, Colm, Dominguez, Maria, McConnell, Vivienne, Willcox, Nick, Meager, Anthony · 2008 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: In autoimmune polyendocrinopathy syndrome type I (APS-I), mutations in the autoimmune regulator gene (AIRE) impair thymic self-tolerance induction in developing T cells. The ensuing autoimmunity particularly targets ectodermal and endocrine tissues, but chronic candidiasis usually comes first. We recently reported apparently APS-I-specific high-titer neutralizing autoantibodies against type I interferons in 100% of Finnish and Norwegian patients, mainly with two prevalent AIRE truncations. Objectives: Because variability in clinical features and age at onset in APS-I frequently results in unusual presentations, we prospectively checked the diagnostic potential of anti-interferon antibodies in additional APS-I panels with other truncations or rare missense mutations and in disease controls with chronic mucocutaneous candidiasis (CMC) but without either common AIRE mutation. Design: The study was designed to detect autoantibodies against interferon-α2 and interferon-ω in antiviral neutralization assays. Setting and Patients: Patients included 14 British/Irish, 15 Sardinian, and 10 Southern Italian AIRE-mutant patients with APS-I; also 19 other patients with CMC, including four families with cosegregating thyroid autoimmunity. Outcome: The diagnostic value of anti-interferon autoantibodies was assessed. Results: We found antibodies against interferon-α2 and/or interferon-ω in all 39 APS-I patients vs. zero of 48 unaffected relatives and zero of 19 British/Irish CMC patients. Especially against interferon-ω, titers were nearly always high, regardless of the exact APS-I phenotype/duration or AIRE genotype, including 12 different AIRE length variants or 10 point substitutions overall (n = 174 total). Strikingly, in one family with few typical APS-I features, these antibodies cosegregated over three generations with autoimmune hypothyroidism plus a dominant-negative G228W AIRE substitution. Conclusions: Otherwise restricted to patients with thymoma and/or myasthenia gravis, these precocious persistent antibodies show 98% or higher sensitivity and APS-I specificity and are thus a simpler diagnostic option than detecting AIRE mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2008-0935

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 209

Metadata

Authors
Meloni, A., Furcas, M., Cetani, F., Marcocci, C., Falorni, A., Perniola, R., Pura, M., Bøe Wolff, A. S., Husebye, E. S., Lilic, D., Ryan, K. R., Gennery, A. R., Cant, A. J., Abinun, M., Spickett, G. P., Arkwright, P. D., Denning, D., Costigan, C., Dominguez, M., McConnell, V., Willcox, N., & Meager, A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2008-11-01
Volume
93
Issue
11
Pages
4389-4397
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2125902352
Cited by
209
References
2
FWCI
5.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. https://app.cochat.ai/papers/10.1210/jc.2008-0935
The paper
Meloni, A., Furcas, M., Cetani, F., Marcocci, C., Falorni, A., Perniola, R., Pura, M., Bøe Wolff, A. S., Husebye, E. S., Lilic, D., Ryan, K. R., Gennery, A. R., Cant, A. J., Abinun, M., Spickett, G. P., Arkwright, P. D., Denning, D., Costigan, C., Dominguez, M., . . . Meager, A. (2008). Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-0935

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.